Metraipolis › archive › dc_8d7df07b6e2c

Controlled delivery of nilotinib using LDH/Fe2O3-modified chitosan nanocomposite hydrogel beads for the treatment of chronic myeloid leukemia — Europe PMC PMID:42270788

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42270788
DOI
10.1038/s41598-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-31T15:14:27.026Z
SHA-256 of the archived text
273156ee5e711ffdf945e7dc6abdc606a29b081b866bc644b7577770a5e253d6
Stable URL of this page
https://metraipolis.com/documento/dc_8d7df07b6e2c

How to cite

Controlled delivery of nilotinib using LDH/Fe2O3-modified chitosan nanocomposite hydrogel beads for the treatment of chronic myeloid leukemia — Europe PMC PMID:42270788 — Europe PMC (en), https://europepmc.org/article/MED/42270788 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d7df07b6e2c (Metraipolis archive dc_8d7df07b6e2c, sha256 273156ee5e711ffdf945e7dc6abdc606a29b081b866bc644b7577770a5e253d6)
BibTeX
@misc{dc8d7df07b6e2c,
  title = {Controlled delivery of nilotinib using LDH/Fe2O3-modified chitosan nanocomposite hydrogel beads for the treatment of chronic myeloid leukemia — Europe PMC PMID:42270788},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42270788},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d7df07b6e2c; sha256 273156ee5e711ffdf945e7dc6abdc606a29b081b866bc644b7577770a5e253d6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42270788. Agents can read the archived copy with the MCP tool read_document.